help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamoto, Y.
Right arrow Articles by Morii, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, Y.
Right arrow Articles by Morii, H.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 730-734, Copyright © 1989 by Endocrine Society


ARTICLES

Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease

Y Okamoto, N Hamada, H Saito, M Ohno, J Noh, K Ito and H Morii
Second Department of Internal Medicine, Osaka City University Medical School, Japan.

The thyroid microsomal antibody (M-Ab) has been found to be an antibody against thyroid peroxidase (TPO), and such antibodies have been reported not only to bind TPO but also to directly inhibit TPO activity. In this study we investigated the relationship between TPO activity-inhibiting immunoglobulin (TPII) and thyroid function in 55 untreated patients with hyperthyroidism due to Graves' disease and 35 untreated patients with Hashimoto's disease. TPO partially purified from the microsomal fraction of Graves' thyroid tissue by Sephacryl S- 300 gel filtration was incubated with immunoglobulin (Ig) fractions of serum prepared by precipitation with 15% polyethylene glycol. At the end of incubation, TPO activity was measured by a guaiacol assay. The TPII level was expressed as the TPII index, defined as the inhibition of TPO activity by patient Ig divided by inhibition produced by a known positive Ig. We also measured serum free T4, free T3, and TSH concentrations and anti-M-Ab titers, the latter by a microenzyme-linked immunosorbent assay. When a positive TPII index was defined as more than the mean + 2 SD of the TPII index (0.38) for 15 normal subjects, 13 patients with Graves' disease and 14 patients with Hashimoto's disease had positive TPII index values. There was a positive correlation between the TPII index values and the M-Ab titers in patients with either Graves' disease (r = 0.38; P less than 0.01) or Hashimoto's disease (r = 0.52; P less than 0.01). The mean TPII index in patients with Hashimoto's disease was significantly higher than that in patients with Graves' disease [0.38 +/- 0.42 (+/- SD) vs. 0.19 +/- 0.41; P less than 0.05]. The slope of the regression line between the TPII index values and the M-Ab titers for patients with Hashimoto's disease was steeper than that for patients with Graves' disease. The mean serum free T4 concentration was significantly lower in those patients with Hashimoto's disease who had positive TPII index values than in those with negative TPII index values (14.0 +/- 5.0 vs. 9.6 +/- 3.7 pmol/L; P less than 0.01). There was no significant difference in thyroid function between the patients with Graves' disease with positive and negative TPII index values. TPII appears to inhibit thyroid function in some patients, but no simple relationship between TPII and thyroid function in autoimmune thyroid disease was demonstrated. Understanding the factors that control access of anti-TPO antibody to its antigen may help to elucidate the significance of circulating anti-TPO antibody.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Estienne, C. Duthoit, L. Vinet, J.-M. Durand-Gorde, P. Carayon, and J. Ruf
A Conformational B-cell Epitope on the C-terminal End of the Extracellular Part of Human Thyroid Peroxidase
J. Biol. Chem., April 3, 1998; 273(14): 8056 - 8062.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
V. Kaczur, Gy. Vereb, I. Molnar, G. Krajczar, E. Kiss, N. R. Farid, and Cs. Balazs
Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay
Clin. Chem., August 1, 1997; 43(8): 1392 - 1396.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R.-T. Tsai, T.-C. Chang, C.-R. Wang, S.-L. Lee, C.-J. Wang, and G.J. Tsay
Thyroid peroxidase autoantibodies and their effects on enzyme activity in patients with systemic lupus erythematosus
Lupus, August 1, 1995; 4(4): 280 - 285.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society